pharma · Extensive-stage Small Cell Lung Cancer · Gastric Cancer
Shanghai Medical College
Fudan University
Fudan University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Extensive-stage Small Cell Lung Cancer, Gastric Cancer, Hodgkin Lymphoma, Cancer of Unknown Primary Site. NovaPharmaN
CN HQ
20 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 20
- Programs
- 4
- Drugs
- 3
- Patents
- 0
tissue-of-origin (ORIGIN-PanCA○R) profiling
Phase 3 · gene therapy · Cancer of Unknown Primary Site
tissue-of-origin (ORIGIN-PanCA○R) profiling for Cancer of Unknown Primary Site is a Phase 3 program (gene_therapy) at Fudan University with 1 ClinicalTrials.gov record(s).
Internal code Fudan CUP-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Fudan University
- Phase
- Phase 3
- Modality
- gene_therapy
- Indication
- Cancer of Unknown Primary Site
- Status
- completed
- Trials
- 1